IP Library Granted Patent US 7,148,322
Granted Patent B2
US 7,148,322 · App. 10/867,070 · Granted Dec 12, 2006

Process for the preparation of echinocandin derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,148,322
App. No.
10/867,070
Granted
Dec 12, 2006
Kind
B2
Abstract

A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them. The process for preparing formula (I) leads to greater than 50% yields of isomer A, and its intended use, e.g. as an antifungal medicament.

Claims (57)

1. A process for the preparation of compounds of formula (I), unsalified forms thereof, and salts thereof

in which R represents a linear or branched or cyclic chain containing up to 30 carbon atoms, optionally containing one or more heteroatoms and one or more heterocycles,

the process comprising:

a) a compound of formula III is provided

b) the compound of formula (III) is subjected to an alkylation reaction of the alcohol in position 5 by the action of an alcohol of formula Alk-OH in the presence of pyridinium p-toluenesulfonate (PPTS), Alk representing an alkyl radical containing 1 to 4 carbon atoms, in order to obtain the compound of formula (III′)

c) the compound of formula (III) or (III′) is subjected to a dehydration reaction, in order to obtain a compound of formula

d) the compound of formula (IV) is subjected to a reducing amination reaction by the action of ethylene diamine in the presence of a reducing agent comprising NaBH 3 CN in the presence of a Lewis acid, or NaBH(OCOR′) 3 , OCOR′ representing Boc-L-Pro, Bzl-L-Pro or any other optically active amino acid as well as any other chiral or non chiral carboxylic acid, in order to obtain the compound of formula (I) as defined above, comprising a majority of one of the active isomers, said compound of formula (I) then being optionally subjected to the one or more of the following operations, chromatography, crystallization, the action of a base to form an unsalified compound, and salification.

2. The process according to claim 1 in which the compounds of formulae (I), (III), (III′) or (IV) contain an R radical selected from the following groups:

3. The process according to claim 1 in which the compounds of formulae (I), (III), (III′), (IV) contain an R radical selected from the following group:

4. The process, according to claim 1 for the preparation of the compound of formula (Ia), unsalified forms thereof, and salts thereof

the process comprising:

a) a compound of formula IIIa is provided

b) the compound of formula (IIIa) is subjected to an alkylation reaction of the alcohol in position 5 by the action of methanol in the presence of pyridinium p-toluenesulfonate (PPTS), in order to obtain the compound of formula (IIIa′)

c) the compound of formula (IIIa) or (IIIa′) is subjected to a dehydration reaction, in order to obtain the compound of formula (IVa),

d) the compound of formula (IVa) is subjected to a reducing amination reaction by the action of ethylene diamine in the presence of a reducing agent comprising NaBH 3 CN coupled with TiCl 4 , NaBH(Boc-L-Pro) 3 or NaBH(Bzl-L-Pro) 3 , in order to obtain the compound of formula (Ia) as defined above, comprising a majority of the active isomer, said compound of formula (Ia) being optionally subjected to one or more of the following operations, chromatography, crystallization, the action of a base, and salification by the action of hydrochloric acid.

5. The process according to claim 4 characterized in that the compound of formula (Ia) is successively subjected to the following operations:

a) purification by chromatography on silica then by reversed-phase chromatography using a mixture of organic solvents, water and trifluoroacetic acid in order to obtain the trifluoroacetic acid salt of the compound of formula (Ia)

b) the action of a base by the action of an aqueous solution of sodium bicarbonate, in order to obtain the unsalified compound of formula (Ia), and

c) salification by the action of hydrochloric acid in order to obtain the corresponding salt, the dihydrochloride of the compound of formula (Ia).

6. The process of claim 4 wherein subpart (a) includes a compound of formula (II)

is subjected to the action of an acid of formula C 8 H 17 —O-Ph-Ph-CO 2 H, or an activated form thereof, in order to obtain the compound of formula (IIIa).

7. The process of claim 1 wherein subpart (a) includes a compound of formula (II)

is subjected to the action of an acid of formula R—CO 2 H, or an activated form thereof, in order to obtain the compound of formula (III).

8. The process according to claim 7 , wherein the activation reaction of the acid is carried out in the presence of pentafluorophenol, N-hydroxysuccinimide or optionally N-hydroxybenzotriazole.

9. The process according to claim 7 wherein the acylation reaction in the presence of the acid, or the activated form thereof is carried out in the presence of diisopropylethylamine.

10. The process according to claim 7 , wherein the activation reaction then the acylation reaction in the presence of the activated acid, is carried out in the presence of N-methyl pyrrolidone and 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-myl-morpholinium chloride (DMTMM).

11. The process according to claim 1 , wherein the dehydration reaction is carried out in the presence of αacetoxyisobutyryl bromide (AIBB) and optionally MgI 2 .

12. The process according to claim 1 , wherein the dehydration reaction is carried out in the presence of HBr-AcOH and of MgI 2 .

13. Process according to claim 1 , wherein the reducing amination reaction is carried out in the presence of a reducing agent chosen from NaBH 3 CN coupled with TiCl 4 , NaBH(Boc-L-pro) 3 and_NaBH (Bzl-L-Pro) 3 .

14. The process according to claim 11 wherein the product originating from the dehydration is purified by crystallization from a DMF/acetone or DMF/AcOEt mixture.

15. The process according to claim 12 wherein the product originating from the dehydration is purified by crystallization from a DNF/acetone or DMF/AcOEt mixture.

16. A process f or the preparation of compounds of formula (I), unsalified forms thereof, and salts thereof

in which R represents a linear or branched or cyclic chain containing up to 30 carbon atoms, optionally containing one or more heteroatoms and one or more heterocycles, the process comprising:

a) a compound of formula (II)

 is subjected to the action of an acid of formula R—CO 2 H, said acid being, in an activated isolated form or non isolated activated form, in order to obtain the compound of formula (III)

b) optionally, the compound of formula (III) is subjected to an alkylation reaction of the alcohol in position 5 by the action of an alcohol of formula Alk-OH in the presence of pyridiniurn p-toluenesulfonate (PPTS), Alk representing an alkyl radical containing 1 to 4 carbon atoms, in order to obtain the compound of formula (III′)

c) the compound of formula (III) or (III′) is subjected to a dehydration reaction, in order to obtain a compound of formula (IV)

d) the compound of formula (IV) is subjected to a reducing amination reaction by the action of ethylene diamine in the presence of a reducing agent, in order to obtain the compound of formula (I) as defined above, comprising a majority of one of the active isomers, said compound of formula (I) then optionally being subjected to the one or more of the following operations, chromatography, crystallization, the action of a base to form an unsalified compound, and salification; and

wherein the activation reaction then the acylation reaction in the presence of the acid, is carried out in the presence of N-methyl pyrrolidone and 4-(4,6-dimethoxy-1,3,5-triazin-2-yl) -4-myl-morpholinium chloride (DMTMM).

17. A process for the preparation of compounds of formula (I), unsalified forms thereof, and salts thereof

in which R represents a linear or branched or cyclic chain containing up to 30 carbon atoms, optionally containing one or more heteroatoms and one or more heterocycles, the process comprising:

a) a compound of formula (II)

 is subjected to the action of an acid of formula R—CO 2 H, said acid being, in an activated isolated form or non isolated activated form, in order to obtain the compound of formula (III)

b) optionally, the compound of formula (III) is subjected to an alkylation reaction of the alcohol in position 5 by the action of an alcohol of formula Alk-OH in the presence of pyridinium p-toluenesulfonate (PPTS), Alk representing an alkyl radical containing 1 to 4 carbon atoms, in order to obtain the compound of formula (III′)

c) the compound of formula (III) or (III′) is subjected to a dehydration reaction, in order to obtain a compound of formula (IV)

d) the compound of formula (IV) is subjected to a reducing amination reaction by the action of ethylene diamine in the presence of a reducing agent, in order to obtain the compound of formula (I) as defined above, comprising a majority of one of the active isomers, said compound of formula (I) then optionally being subjected to the one or more of the following operations, chromatography, crystallization, the action of a base to form an unsalified compound, and salification; and

wherein the dehydration reaction is carried out in the presence of α-acetoxyisobutyryl bromide (AIBB) and optionally, MgI 2 .

18. The process according to claim 17 wherein the product originating from the dehydration is purified by crystallization from a DMF/acetone or DMF/AcOEt mixture.

19. A process for the preparation of compounds of formula (I), unsalified forms thereof, and salts thereof

in which R represents a linear or branched or cyclic chain containing up to 30 carbon atoms, optionally containing one or more heteroatoms and one or more heterocycles, the process comprising:

a) a compound of formula (II)

 is subjected to the actien of an acid of formula R—CO 2 H, said acid being, in an activated isolated form or non isolated activated form, in order to obtain the compound of formula (III)

b) optionally, the compound of formula (III) is subjected to an alkylation reaction of the alcohol in position 5 by the action of an alcohol of formula Alk-OH in the presence of pyridinium p-toluenesulfonate (PPTS), Alk representing an alkyl radical containing 1 to 4 carbon atoms, in order to obtain the compound of formula (III′)

c) the compound of formula (III) or (III′) is subjected to a dehydration reaction, in order to obtain a compound of formula (IV)

d) the compound of formula (IV) is subjected to a reducing amination reaction by the action of ethylene diamine in the presence of a reducing agent, in order to obtain the compound of formula (I) as defined above, comprising a majority of one of the active isomers, said compound of formula (I) then optionally being subjected to the one or more of the following operations, chromatography, crystallization, the action of a base to form an unsalified compound, and salification; and

wherein the dehydration reaction is carried out in the presence of HBr-AcOH and of MgI 2 .

20. The process according to claim 19 wherein the product originating from the dehydration is purified by crystallization from a DMF/acetone or DMF/AcCEt mixture.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2006
From: AVENTIS PHARMA S.A.
To: NOVEXEL
Reel/Frame 018545/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2006
From: AVENTIS PHARMA S.A.
To: NOVEXEL SA
Reel/Frame 018440/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2004
From: BOFFELLI, PHILIPPE; BROUILLARD, AGNES; COLLADANT, COLETTE; DROUX, SERGE; ELTER, MICHEL; FERROUD, DIDIER; LAMAITRE, GUY; PALADINO, JOSEPH
To: AVENTIS PHARMA S.A.
Reel/Frame 015349/0924 →
Priority Claims (1)
FR 01 16230 · Dec 14, 2001 · national
Continuity (2)
Continuation PCTFR020430800 · Dec 12, 2002
Related Publication 20050032679A1 · Feb 10, 2005